Trade PLSE anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
Pulse Biosciences, Inc Common Stock (DE) (PLSE) is trading at US$53.24, down 2.69% today as of Sep 4, 16:00 EDT. The company has a market capitalisation of US$3.6B. Over the past 52 weeks, PLSE has traded between US$12.56 and US$55.37. On Syfe you can trade PLSE with $0 commission and add it to your watchlist.
| Previous close | US$54.71 |
|---|---|
| Market cap | US$3.6B |
| 52-week range | US$12.56 – US$55.37 |
| Volume | 514.66K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Pulse Biosciences, Inc Common Stock (DE)
Pulse Biosciences, Inc. operates as an immuno-oncology company developing a proprietary oncolytic electroceutical therapy based on its Nano Pulse Stimulation (NPS) technology. It manufactures surgical and medical instruments using a novel and proprietary platform technology called Nano-Pulse Electro-Signaling. The NPES provides local tumor control and initiates an adaptive immune response with a vaccine-like effect by inducing immunogenic apoptosis of the cells. The company was founded on May 19, 2014 and is headquartered in Miami, FL.
Year: 2016
Pulse Biosciences, Inc Common Stock (DE) (PLSE) stock is trading at US$53.24, -2.69% from the previous close of US$54.71.
The market cap for Pulse Biosciences, Inc Common Stock (DE) (PLSE) stock is approximately US$3.6B.
The 52-week high for Pulse Biosciences, Inc Common Stock (DE) (PLSE) stock is US$55.37.
The 52-week low for Pulse Biosciences, Inc Common Stock (DE) (PLSE) stock is US$12.56.
Pulse Biosciences, Inc Common Stock (DE) (PLSE) does not currently pay a dividend.
Stay on top of PLSE
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
